Sea Limited's latest earnings reveal a strategic pivot back to aggressive investment in its e-commerce arm, Shopee, driving robust revenue growth but squeezing near-term margins. This move reignites the debate on whether the Southeast Asian tech giant can sustainably balance expansion with profitability.
Celestica's Q4 2025 results shattered guidance, fueled by its Connectivity & Cloud unit. The company announces a massive capital expenditure surge to over $1 billion in 2026, betting big on sustained demand from hyperscalers for AI and networking infrastructure.
The iconic Berkeley-born coffee chain Peet's is closing dozens of locations across California, including in Southern California and the Bay Area, as part of a strategic realignment following its acquisition by Keurig Dr Pepper. The move, affecting hundreds of employees, has drawn sharp criticism from workers and union representatives.
President Trump is preparing to nominate former Fed Governor Kevin Warsh to lead the central bank, according to people familiar with the discussions, a move that triggered immediate market reactions as investors assessed the potential policy shift.
President Trump is expected to nominate former Fed governor Kevin Warsh as the next Federal Reserve Chair, a move that could signal a pivot toward aggressive rate cuts paired with a reduction of the central bank's balance sheet, reshaping the landscape for markets and cryptocurrencies.
GSK makes a dual strategic move, acquiring RAPT Therapeutics for its food allergy portfolio and securing broader European approval for its RSV vaccine Arexvy, reinforcing its focus on immunology and respiratory health.
Marriott International's shares have delivered impressive multi-year gains, but recent analysis suggests the hospitality giant's stock may now be trading at a significant premium. With a DCF model pointing to a 16% overvaluation and a P/E ratio exceeding industry peers, investors are debating whether the price fully reflects future growth or has outpaced fundamentals.
Bread Financial (NYSE: BFH) delivered robust fourth-quarter and full-year 2025 results, meeting expectations through strategic partner expansions, improved credit health, and strengthened capital positioning. Management outlines a 2026 roadmap focused on sustainable growth, deposit mix optimization, and leveraging AI across operations.
British pharmaceutical giant AstraZeneca has entered a strategic partnership with China's CSPC Pharmaceutical, committing over $1 billion upfront to co-develop next-generation obesity therapies, signaling intensified competition in the lucrative global weight-loss drug market.
Target is launching its largest-ever spring beauty collection, introducing over 3,000 new, predominantly budget-friendly items alongside redesigned in-store experiences and key leadership appointments, signaling a major strategic push to capture market share in the lucrative beauty sector.
Apple shattered earnings expectations in its fiscal first quarter, fueled by a remarkable resurgence in iPhone sales across Greater China. While navigating supply constraints, the tech giant is betting big on a new AI partnership with Google to power its next chapter.
Aon plc (NYSE: AON) is in the spotlight following the launch of a major emerging markets climate transition fund with Irish Life Investment Managers. The move expands its sustainable investment footprint to over €1 billion as analysts scrutinize whether its current share price fully reflects future growth prospects amid a mixed performance backdrop.
Rigetti Computing's roadmap hits a snag as it delays its next-generation 108-qubit processor to address error rates and fails to advance in a strategic DARPA program. The dual setbacks intensify scrutiny on the company's competitive position against well-funded rivals in the race for practical quantum computing.
Apple's fiscal Q1 2026 results, fueled by "staggering" demand for the iPhone 17, delivered record revenue and a dramatic turnaround in China, silencing critics and reigniting growth.
